-
Most Popular
![Healthcare Stocks Icon](https://investorplace.com/wp-content/uploads/2022/12/healthcare-150x150.png)
Healthcare Stocks
Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.
![The words "recession proof" written on a pink sticky note. bulletproof stocks](https://investorplace.com/wp-content/uploads/2023/07/shutterstock_2170602547-150x150.jpg)
7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024
These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.
![Interest rate and dividend concept. Businessman with percentage symbol and up arrow, Interest rates continue to increase, return on stocks and mutual funds, long term investment for retirement. Dividend stocks](https://investorplace.com/wp-content/uploads/2024/06/dividend-stocks1600-5-150x150.png)
7 Dependable Dividend Stocks for Long-Term Income
Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.
![medicine research, pharmaceutical background, LJPC stock](https://investorplace.com/wp-content/uploads/2022/03/pharmaceuticals_tnxp_1600-150x150.png)
3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct
These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.
Recent Healthcare Stocks Articles
Why Is Miromatrix Medical (MIRO) Stock Up 235% Today?
Miromatrix Medical stock is rocketing higher on Monday after the company reached an acquisition agreement with United Therapeutics for MIRO.
CRSP Stock: FDA Considers Additional Review of CRISPR Therapeutics Gene Therapy
Although CRISPR Therapeutics may have a breakthrough drug on its hands, regulatory concerns hang over CRSP stock.
SNY Stock Sinks 15% as Sanofi Plans Consumer Unit Spinoff
The happy talk in Sanofi's press release didn't help with analysts, who have been disappointed in the company and SNY stock all year.
ALGN Stock Alert: Align Technology Announces $250M Stock Buyback Program
Align Technology stock is rising on Friday after the company announced plans to repurchase $250 million worth of ALGN shares.
Millionaire Secrets: 3 Stocks to Turn $1,000 Into a Fortune
Are you looking to invest in the stock market and become a millionaire? Here are three stocks to buy to turn $1,000 into a fortune.
Why Is PTC Therapeutics (PTCT) Stock Down 23% Today?
PTC Therapeutics stock is falling on Friday as PTCT investors react to the company's lackluster earnings report for Q3 2023.
Why Is TransCode Therapeutics (RNAZ) Stock Down 25% Today?
TransCode Therapeutics stock is falling on Friday after the company announced plans for a public offering of RNAZ shares.
Why Is Apollomics (APLM) Stock Up 113% Today?
Apollomics stock is taking off on Friday with heavy trading of APLM following its latest study news presented to traders yesterday.
Why Is NKGen Biotech (NKGN) Stock Up 18% Today?
NKGen Biotech stock is taking off on Friday as NKGN investors react to the company's clinical trial results for its Alzheimer’s treatment.
Why Is PaxMedica (PXMD) Stock Up Today?
PaxMedica recently demonstrated encouraging progress with a key therapeutic, but PXMD stock remains highly speculative.
Why Is Theratechnologies (THTX) Stock Down 22% Today?
Theratechnologies stock is falling hard on Thursday after the company priced a public offering and private placement for THTX shares.
Why Is Align Technology (ALGN) Stock Down 23% Today?
Align Technology stock is taking a beating on Thursday as investors in ALGN react to the company's lackluster earnings report for Q3!
3 Cannabis Penny Stocks With Millionaire-Making Potential
Cannabis stocks have remained depressed for an extended period and have been investor wealth destroyers. Regulatory headwinds have been the key reason for stocks underperforming.…